ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Annual Report to the Nation Shows Decline In Overall Cancer Death Rates

January 11, 2013

Fibrolast Interferon Contract Signed

May 2, 1980

Collins, Lander, Botstein Win Albany Prize.

March 12, 2010

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

NCI Prepares For Intramural Program Review

June 27, 2014

NCI Phone Number Listings Completed

September 21, 1979